Keywords: orbit, data, support, phase, iii, studies, xemilofiban

ORBIT Data Support Phase III Studies Of Xemilofiban

Article | 13 November 1997

Print This

Searle's xemilofiban is in the forefront of the new orally-activeglycoprotein IIb/IIIa inhibitors coming through development for use in acute ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in